Vikhyat S Bebarta1, Matthew Brittain2, Adriano Chan3, Norma Garrett4, David Yoon5, Tanya Burney5, David Mukai5, Michael Babin2, Renate B Pilz3, Sari B Mahon5, Matthew Brenner5, Gerry R Boss3. 1. Department of Emergency Medicine, University of Colorado, School of Medicine, Aurora, CO. 2. Battelle Memorial Institute, Columbus, OH. 3. Department of Medicine, University of California, San Diego, La Jolla, CA. 4. Medical Toxicology and the Department of Emergency Medicine, San Antonio Military Medical Center/59 MDW, San Antonio, TX. 5. Beckman Laser Institute and Medical Clinic, University of California, Irvine, Irvine, CA.
Abstract
STUDY OBJECTIVE: The 2 antidotes for acute cyanide poisoning in the United States must be administered by intravenous injection. In the out-of-hospital setting, intravenous injection is not practical, particularly for mass casualties, and intramuscular injection would be preferred. The purpose of this study is to determine whether sodium nitrite and sodium thiosulfate are effective cyanide antidotes when administered by intramuscular injection. METHODS: We used a randomized, nonblinded, parallel-group study design in 3 mammalian models: cyanide gas inhalation in mice, with treatment postexposure; intravenous sodium cyanide infusion in rabbits, with severe hypotension as the trigger for treatment; and intravenous potassium cyanide infusion in pigs, with apnea as the trigger for treatment. The drugs were administered by intramuscular injection, and all 3 models were lethal in the absence of therapy. RESULTS: We found that sodium nitrite and sodium thiosulfate individually rescued 100% of the mice, and that the combination of the 2 drugs rescued 73% of the rabbits and 80% of the pigs. In all 3 species, survival in treated animals was significantly better than in control animals (log rank test, P<.05). In the pigs, the drugs attenuated an increase in the plasma lactate concentration within 5 minutes postantidote injection (difference: plasma lactate, saline solution-treated versus nitrite- or thiosulfate-treated 1.76 [95% confidence interval 1.25 to 2.27]). CONCLUSION: We conclude that sodium nitrite and sodium thiosulfate administered by intramuscular injection are effective against severe cyanide poisoning in 3 clinically relevant animal models of out-of-hospital emergency care.
STUDY OBJECTIVE: The 2 antidotes for acute cyanidepoisoning in the United States must be administered by intravenous injection. In the out-of-hospital setting, intravenous injection is not practical, particularly for mass casualties, and intramuscular injection would be preferred. The purpose of this study is to determine whether sodium nitrite and sodium thiosulfate are effective cyanide antidotes when administered by intramuscular injection. METHODS: We used a randomized, nonblinded, parallel-group study design in 3 mammalian models: cyanide gas inhalation in mice, with treatment postexposure; intravenous sodium cyanide infusion in rabbits, with severe hypotension as the trigger for treatment; and intravenous potassium cyanide infusion in pigs, with apnea as the trigger for treatment. The drugs were administered by intramuscular injection, and all 3 models were lethal in the absence of therapy. RESULTS: We found that sodium nitrite and sodium thiosulfate individually rescued 100% of the mice, and that the combination of the 2 drugs rescued 73% of the rabbits and 80% of the pigs. In all 3 species, survival in treated animals was significantly better than in control animals (log rank test, P<.05). In the pigs, the drugs attenuated an increase in the plasma lactate concentration within 5 minutes postantidote injection (difference: plasma lactate, saline solution-treated versus nitrite- or thiosulfate-treated 1.76 [95% confidence interval 1.25 to 2.27]). CONCLUSION: We conclude that sodium nitrite and sodium thiosulfate administered by intramuscular injection are effective against severe cyanidepoisoning in 3 clinically relevant animal models of out-of-hospital emergency care.
Authors: Jae G Kim; Jangwoen Lee; Sari B Mahon; David Mukai; Steven E Patterson; Gerry R Boss; Bruce J Tromberg; Matthew Brenner Journal: J Biomed Opt Date: 2012-10 Impact factor: 3.170
Authors: Matthew Brenner; Sari B Mahon; Jangwoen Lee; Jae Kim; David Mukai; Seth Goodman; Kelly A Kreuter; Rebecca Ahdout; Othman Mohammad; Vijay S Sharma; William Blackledge; Gerry R Boss Journal: J Biomed Opt Date: 2010 Jan-Feb Impact factor: 3.170
Authors: Adriano Chan; Jingjing Jiang; Alla Fridman; Ling T Guo; G Diane Shelton; Ming-Tao Liu; Carol Green; Kristofer J Haushalter; Hemal H Patel; Jangwoen Lee; David Yoon; Tanya Burney; David Mukai; Sari B Mahon; Matthew Brenner; Renate B Pilz; Gerry R Boss Journal: J Med Chem Date: 2015-02-16 Impact factor: 7.446
Authors: Lilli Stephenson; Stephen Wills; Corinna van den Heuvel; Melissa Humphries; Roger W Byard Journal: Forensic Sci Med Pathol Date: 2022-03-25 Impact factor: 2.456
Authors: Jordan Morningstar; Jangwoen Lee; Tara Hendry-Hofer; Alyssa Witeof; L Tiffany Lyle; Gregg Knipp; Calum A MacRae; Gerry R Boss; Randall T Peterson; Vincent J Davisson; Robert E Gerszten; Vikhyat S Bebarta; Sari Mahon; Matt Brenner; Anjali K Nath Journal: FASEB Bioadv Date: 2018-10-08
Authors: Adriano Chan; Jangwoen Lee; Subrata Bhadra; Nesta Bortey-Sam; Tara B Hendry-Hofer; Vikhyat S Bebarta; Sari B Mahon; Matthew Brenner; Brian Logue; Renate B Pilz; Gerry R Boss Journal: Clin Toxicol (Phila) Date: 2021-07-30 Impact factor: 4.467
Authors: Adrian Thompson; Michael Dunn; Robert D Jefferson; Kosala Dissanayake; Frances Reed; Rachael Gregson; Stephen Greenhalgh; R Eddie Clutton; Peter G Blain; Simon Hl Thomas; Michael Eddleston Journal: Clin Toxicol (Phila) Date: 2019-08-07 Impact factor: 4.467